Literature DB >> 18464758

Inhaled insulin's last gasp?

Jim Kling.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18464758     DOI： 10.1038/nbt0508-479

Source DB:  PubMed          Journal:  Nat Biotechnol        ISSN： 1087-0156            Impact factor:   54.908


× No keyword cloud information.
  12 in total

1.  Dreamboat sinks prospects for fast approval of inhaled insulin.

Authors:  Jim Kling
Journal:  Nat Biotechnol       Date:  2011-03       Impact factor: 54.908

Review 2.  Do nanomedicines require novel safety assessments to ensure their safety for long-term human use?

Authors:  Peter Hoet; Barbara Legiest; Jorina Geys; Benoit Nemery
Journal:  Drug Saf       Date:  2009       Impact factor: 5.606

3.  Respirable low-density microparticles formed in situ from aerosolized brittle matrices.

Authors:  Alan B Watts; Yi-Bo Wang; Keith P Johnston; Robert O Williams
Journal:  Pharm Res       Date:  2012-11-15       Impact factor: 4.200

Review 4.  Inhaled aerosolized insulin: a "topical" anti-inflammatory treatment for acute lung injury and respiratory distress syndrome?

Authors:  Haim Shapiro; Ilya Kagan; Michal Shalita-Chesner; Joelle Singer; Pierre Singer
Journal:  Inflammation       Date:  2010-10       Impact factor: 4.092

Review 5.  The insulin and insulin-like growth factor receptor family in neoplasia: an update.

Authors:  Michael Pollak
Journal:  Nat Rev Cancer       Date:  2012-02-16       Impact factor: 60.716

Review 6.  Inhaled insulin: overview of a novel route of insulin administration.

Authors:  Lucy D Mastrandrea
Journal:  Vasc Health Risk Manag       Date:  2010-03-03

7.  Influence of stabilizers on the physicochemical characteristics of inhaled insulin powders produced by supercritical antisolvent process.

Authors:  Yong Ho Kim; Constantinos Sioutas; Katherine S Shing
Journal:  Pharm Res       Date:  2008-09-04       Impact factor: 4.200

8.  Oncogenic activity of insulin in the development of non-small cell lung carcinoma.

Authors:  Jie Jiang; Hong-Yue Ren; Guo-Jun Geng; Yan-Jun Mi; Yu Liu; Ning Li; Shu-Yu Yang; Dong-Yan Shen
Journal:  Oncol Lett       Date:  2017-11-03       Impact factor: 2.967

Review 9.  Pulmonary delivery of therapeutic siRNA.

Authors:  Jenny Ka-Wing Lam; Wanling Liang; Hak-Kim Chan
Journal:  Adv Drug Deliv Rev       Date:  2011-02-26       Impact factor: 15.470

10.  A critical analysis of the clinical use of incretin-based therapies: Are the GLP-1 therapies safe?

Authors:  Peter C Butler; Michael Elashoff; Robert Elashoff; Edwin A M Gale
Journal:  Diabetes Care       Date:  2013-05-03       Impact factor: 19.112
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.